GSK Plc (GSK)
53.39
-0.89
(-1.64%)
USD |
NYSE |
Mar 13, 16:00
53.57
+0.18
(+0.34%)
After-Hours: 20:00
GSK EPS Diluted (Quarterly) : 0.414 for Dec. 31, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| AstraZeneca PLC | 0.743 |
| Biodexa Pharmaceuticals Plc | -- |
| Mereo BioPharma Group Plc | -0.0436 |
| BioNTech SE | -1.448 |
| Rapt Therapeutics, Inc. (DELISTED) | -0.652 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | 966.83M |
| Revenue (Quarterly) | 11.46B |
| Total Expenses (Quarterly) | 10.62B |
| Enterprise Value | 125.63B |
| Gross Profit Margin (Quarterly) | 69.38% |
| Profit Margin (Quarterly) | 8.44% |
| Earnings Yield | 6.86% |
| Operating Earnings Yield | 8.87% |
| Normalized Earnings Yield | 7.408 |